Reuters - Video

Edition: US | UK | IN | CN | JP

video Finance Videos

Biotech M&A boom sees Sanofi snapping up Ablynx

Monday, January 29, 2018 - 01:01

French drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock reports.

▲ Hide Transcript

View Transcript

French drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock reports.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Biotech M&A boom sees Sanofi snapping up Ablynx

Monday, January 29, 2018 - 01:01